Fmr LLC Has $1.07 Billion Stock Holdings in Humana Inc. (NYSE:HUM)

Fmr LLC boosted its stake in shares of Humana Inc. (NYSE:HUM) by 23.4% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 3,388,859 shares of the insurance provider’s stock after buying an additional 643,291 shares during the period. Fmr LLC’s holdings in Humana were worth $1,073,387,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. Ontario Teachers Pension Plan Board lifted its position in Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after acquiring an additional 71,910 shares in the last quarter. Swedbank AB raised its stake in shares of Humana by 3.0% in the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after purchasing an additional 3,085 shares during the period. Heritage Oak Wealth Advisors LLC bought a new stake in shares of Humana in the second quarter valued at about $3,456,000. Charles Schwab Investment Management Inc. boosted its position in shares of Humana by 3.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider’s stock worth $284,810,000 after buying an additional 26,056 shares during the period. Finally, Mandatum Life Insurance Co Ltd grew its holdings in shares of Humana by 115.4% during the third quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock worth $4,434,000 after buying an additional 7,500 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Trading Up 0.4 %

Shares of Humana stock opened at $296.83 on Thursday. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $526.47. The stock has a market cap of $35.74 billion, a PE ratio of 26.29, a PEG ratio of 2.40 and a beta of 0.52. The firm has a 50-day moving average of $275.91 and a 200-day moving average of $330.00. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. As a group, sell-side analysts forecast that Humana Inc. will post 15.86 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.19%. Humana’s payout ratio is 31.36%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on HUM. KeyCorp assumed coverage on shares of Humana in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Cantor Fitzgerald restated a “neutral” rating and set a $395.00 price objective on shares of Humana in a research note on Tuesday, October 1st. Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Deutsche Bank Aktiengesellschaft reduced their price target on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Finally, TD Cowen upped their price objective on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.